ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 579,18
0,58%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) Actualités

CELC Celcuity Inc

15,03
-0,31 (-2,02%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Celcuity Inc CELC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,31 -2,02% 15,03 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
15,14 14,98 15,34 15,03 15,34
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:01GLOBECelcuity To Participate in Jefferies Global Healthcare..
31/5/202423:00EDGAR2Form 8-K - Current report
30/5/202423:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/5/202413:36GLOBECelcuity Announces Pricing of Underwritten Common Stock..
30/5/202413:05EDGAR2Form 8-K - Current report
30/5/202413:00GLOBECelcuity Inc. Announces Plan to Initiate a Phase 3 Clinical..
24/5/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202423:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:01GLOBECelcuity Inc. Reports First Quarter Financial Results and..
13/5/202423:00EDGAR2Form 8-K - Current report
08/5/202413:05GLOBECelcuity Inc. Schedules Release of First Quarter 2024..
04/4/202413:05GLOBECelcuity To Present at Upcoming Needham and Stifel Investor..
27/3/202421:01GLOBECelcuity Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202412:05GLOBECelcuity Inc. Schedules Release of Fourth Quarter and Full..
06/3/202413:05GLOBECelcuity to Participate in Leerink Partners Global Biopharma..
28/2/202413:05GLOBECelcuity to Participate in Cowen’s 44th Annual Health Care..
23/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:05GLOBECelcuity Announces First Patient Dosed in Phase 1b/2..
20/2/202413:05GLOBECelcuity Appoints Eldon Mayer as Chief Commercial Officer
15/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202423:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:34EDGAR2Form 144 - Report of proposed sale of securities
06/12/202314:30GLOBECelcuity Presents Preclinical Data on Therapeutic Effects of..
05/12/202323:25EDGAR2Form 8-K - Current report
01/12/202317:02GLOBECelcuity to Present Preclinical Data for Gedatolisib at the..
30/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202314:15EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/11/202314:05GLOBECelcuity to Participate in the 6th Annual Evercore ISI..
13/11/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:35EDGAR2Form 8-K - Current report
13/11/202313:05GLOBECelcuity Inc. Reports Third Quarter 2023 Financial Results..
06/11/202313:30GLOBECelcuity Inc. Schedules Release of Third Quarter 2023..
01/11/202312:05GLOBECelcuity To Present at Upcoming Stifel and Jefferies..
27/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202323:15EDGAR2Form 8-K - Current report
07/9/202322:05GLOBECelcuity to Host Virtual Science Day for Investors
01/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202316:58EDGAR2Form 144 - Report of proposed sale of securities
29/8/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
CELC
Celcuity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés